Furthering their analysis, the researchers tested the impact of PD-1 humanization in mice—replacing mouse PD-1 with the human version—through co-senior author Professor Jack Bui's laboratory ...

“Although current PD-1/ PD-L1-targeting treatments can achieve durable ... α interaction has been shown to inhibit tumor growth in mouse xenograft models. IMC-002 is a fully human IgG ...

A new study, published in the peer-reviewed journal AI in Precision Oncology, examines the ability of large language models ...

The following is a summary of “Efficacy and safety of PD-1/PD-L1 inhibitor monotherapy or combination therapy versus platinum-based chemotherapy as a first-line treatment of advanced urothelial cancer ...

Tislelizumab plus chemotherapy received FDA approval as a frontline therapy for individuals with unresectable or metastatic ...

Technologies announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU ...

Patients with PD-L1-positive tumors lived more than seven months longer on Tevimbra added to chemotherapy compared to just chemo.

CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced that the first patient ...

A new study published in AI in Precision Oncology examines the ability of large language models (LLMs) to rapidly extract ...